CVS Health (CVS) Tops Q4 EPS by 9c, FY EPS Guidance Misses
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $103.07 -1.58%
EPS Growth %: +1.1%
Financial Fact:
Net loss attributable to noncontrolling interest: -1M
Today's EPS Names:
CRMT, PKE, More
EPS Growth %: +1.1%
Financial Fact:
Net loss attributable to noncontrolling interest: -1M
Today's EPS Names:
CRMT, PKE, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q4 EPS of $2.14, $0.09 better than the analyst estimate of $2.05. Revenue for the quarter came in at $54.4 billion versus the consensus estimate of $54.58 billion.
GUIDANCE:
CVS Health sees FY2019 EPS of $6.68-$6.88, versus the consensus of $7.41.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler defends Oracle ahead of earnings, sees $2.2 billion OCI upside
- KeyBanc: 'We Like AT&T (T) and TMUS'
- Solstice to acquire Element Solutions in $14.5B deal
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
